Avirmax Biopharma

Product Pipline

Avirmax Biopharma Inc. is at clinical stage of biotherapeutics development using rAAV delivery system. Currently, it is developing multiple rAAV candidates. The following are examples of Avirmax Biopharma’s product pipelines under development.

  • Program
  • Indication
  • Lead Design & Production
  • AAV - Vector
  • Biochemical
  • Potency
  • Preclinical
  • IND - Enabling
  • Phase 1
  • Commercial Rights
  • Milestone

iCare CNV

wAMD, incl,PCV

ABI-110
0%

IND 1H24

GA

AMI-569
0%

PIND 2H24

iCare   GA

dAMD

AMI-550
0%

PIND 2H24

dAMD

AMI-577
0%

PIND 2H24

iCare NIU

NIU, uvCNV, UMO

ABI-107 , ABI-108
0%

AMD = Age-Related Macular Degeneration
DME = Diabetic Macular Edema
CNV = Choroidal Neovascularization
PCV = Polypoidal Choroidal Vasculopathy
RVO= Retinal Vein Occlusion
GA = Geographic atrophy